The present invention relates to 18-methyl-6,7-methylene-17-pregn-4-ene-21,17&bgr;-carbolactones of general formula I wherein the 6,7-methylene group can be in α- or &bgr; position, pharmaceutical preparations containing at least one isomer of formula I and use thereof in the treatment of endometriosis.